A Study of JR-141 in Patients With Mucopolysaccharidosis II

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A Phase II open-label, randomized, parallel group, 2 sites (Brazil), designed to evaluate the safety and efficacy of 3 doses of study drug for the treatment of the MPS II.
Epistemonikos ID: fdd82a9f7d38813749a2c19d35977576025776c2
First added on: May 21, 2024